Two Decades of Research May Be Reversed by a New Alzheimer’s Discovery
source: pixabay.com

Two Decades of Research May Be Reversed by a New Alzheimer’s Discovery

Alois Alzheimer, a clinical psychiatrist and expert in the study of the nervous system, reported a disease process of the cerebral cortex. The year was 1906. We are approaching July…

Continue Reading Two Decades of Research May Be Reversed by a New Alzheimer’s Discovery
LX2006 Receives Rare Pediatric Disease and Orphan Drug Designations for Friedreich’s Ataxia
source: pixabay.com

LX2006 Receives Rare Pediatric Disease and Orphan Drug Designations for Friedreich’s Ataxia

The FDA grants designations, such as the Rare Pediatric Disease and Orphan Drug designations, to aid in the drug development process. Recently, LEXEO Therapeutics has received these two designations for…

Continue Reading LX2006 Receives Rare Pediatric Disease and Orphan Drug Designations for Friedreich’s Ataxia